Clinical Trial Update: Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial [Phase 1, Phase 2]

View source ↗

Summary

An update on the SCOPE trial evaluating selinexor, pomalidomide, and dexamethasone with or without carfilzomib in relapsed/refractory multiple myeloma; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)
• Pomalyst (pomalidomide)
• Selinexor (selinexor)

Snippet

Sponsor: Mayo Clinic | Conditions: Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING